• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙型肝炎病毒、丙型肝炎病毒和梅毒合并感染在不同途径感染人类免疫缺陷病毒/艾滋病患者中的特征:回顾性研究。

Characteristics of Hepatitis B Virus, Hepatitis C Virus, and Syphilis Coinfection in People With HIV/AIDS Contracted Through Different Sources: Retrospective Study.

机构信息

Zhongnan Hospital of Wuhan University, Wuhan, China.

Center for AIDS Research, Wuhan University, Wuhan, China.

出版信息

JMIR Public Health Surveill. 2024 Feb 27;10:e46750. doi: 10.2196/46750.

DOI:10.2196/46750
PMID:38412004
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10933743/
Abstract

BACKGROUND

The burden of hepatitis B virus (HBV), hepatitis C virus (HCV), and syphilis coinfections remains disproportionately high among people living with HIV/AIDS. Hubei province is located in central China, where there are distinct regional characteristics of the distribution of people living with HIV/AIDS acquired via diverse transmission routes and the AIDS epidemic itself.

OBJECTIVE

We aimed to estimate the magnitude of HBV, HCV, or syphilis coinfections among people living with HIV/AIDS with blood-borne transmission, which includes former paid blood donors, contaminated blood recipients, and intravenous drug users, as well as among people with sex-borne HIV transmission (including heterosexual people and men who have sex with men) and people with mother-to-child HIV transmission.

METHODS

From January 2010 to December 2020, people living with HIV/AIDS were tested for hepatitis B surface antigen (HBsAg), HCV antibodies, and syphilis-specific antibodies. The positive patients were further tested for HBV markers, HBV DNA, and HCV RNA, and received a rapid plasma reagin circle card test. All people living with HIV/AIDS were first divided into transmission groups (blood, sex, and mother-to-child); then, people with blood-borne HIV transmission were divided into former paid blood donors, contaminated blood recipients, and intravenous drug users, while people with sex-borne HIV transmission were divided into heterosexual people and men who have sex with men.

RESULTS

Among 6623 people living with HIV/AIDS, rates of chronic HCV infection were 80.3% (590/735) in former paid blood donors, 73.3% (247/337) in intravenous drug users, 57.1% (444/777) in contaminated blood recipients, 19.4% (21/108) in people with mother-to-child HIV transmission, 8.1% (240/2975) in heterosexual people, and 1.2% (21/1691) in men who have sex with men. Chronic HBV infection rates were similar among all people with blood-borne HIV transmission. However, compared to heterosexual people, the chronic HBV infection rate was greater in men who have sex with men (213/1691, 12.6% vs 308/2975, 10.4%; χ=5.469; P=.02), although HBV exposure was less common (827/1691, 48.9% vs 1662/2975, 55.9%; χ=20.982; P<.001). Interestingly, the combination of HBsAg and hepatitis B e antigen (HBeAg) was found in 11 patients with sex-borne HIV transmission, but in 0 people with blood-borne HIV transmission (11/196, 5.6% vs 0/521, 0%; χ=29.695, P<.001). In people with sex-borne HIV transmission, the proportions of patients with a syphilis titer ≥1:16 and neurosyphilis were 8.6% (105/1227) and 7.8% (37/473), respectively, whereas these values were 0 in people with blood-borne HIV transmission.

CONCLUSIONS

In people living with HIV/AIDS, HCV transmission intensity was significantly associated with specific exposure modes of blood or sexual contact. The rate of chronic HBV infection among men who have sex with men was higher than in any other population. Attention should be paid to the high prevalence of neurosyphilis in people living with HIV/AIDS who contract HIV by sexual intercourse.

摘要

背景

乙型肝炎病毒(HBV)、丙型肝炎病毒(HCV)和梅毒合并感染在艾滋病毒/艾滋病患者中负担过重。湖北省位于中国中部,其艾滋病毒/艾滋病患者的分布具有明显的地域特征,包括通过不同传播途径获得的艾滋病毒感染者和艾滋病患者,以及性传播(包括异性恋者和男男性接触者)和母婴传播的艾滋病毒感染者。

目的

我们旨在评估血液传播途径(包括既往有偿献血者、受污染血液接受者和静脉吸毒者)以及性传播途径(包括异性恋者和男男性接触者)和母婴传播途径的艾滋病毒感染者中 HBV、HCV 或梅毒合并感染的程度。

方法

从 2010 年 1 月至 2020 年 12 月,对艾滋病毒感染者进行乙型肝炎表面抗原(HBsAg)、丙型肝炎抗体和梅毒特异性抗体检测。阳性患者进一步检测 HBV 标志物、HBV DNA 和 HCV RNA,并接受快速血浆反应素环状卡片试验。所有艾滋病毒感染者首先分为传播组(血液、性和母婴);然后,血液传播的艾滋病毒感染者分为既往有偿献血者、受污染血液接受者和静脉吸毒者,而性传播的艾滋病毒感染者分为异性恋者和男男性接触者。

结果

在 6623 名艾滋病毒感染者中,既往有偿献血者的慢性 HCV 感染率为 80.3%(590/735),静脉吸毒者为 73.3%(247/337),受污染血液接受者为 57.1%(444/777),母婴传播的艾滋病毒感染者为 19.4%(21/108),异性恋者为 8.1%(240/2975),男男性接触者为 1.2%(21/1691)。所有血液传播的艾滋病毒感染者的慢性 HBV 感染率相似。然而,与异性恋者相比,男男性接触者的慢性 HBV 感染率更高(213/1691,12.6%比 308/2975,10.4%;χ=5.469;P=.02),尽管 HBV 暴露的情况较少(827/1691,48.9%比 1662/2975,55.9%;χ=20.982;P<.001)。有趣的是,在性传播的艾滋病毒感染者中发现了 11 例 HBsAg 和乙型肝炎 e 抗原(HBeAg)联合阳性患者,但在血液传播的艾滋病毒感染者中未发现(11/196,5.6%比 0/521,0%;χ=29.695,P<.001)。在性传播的艾滋病毒感染者中,梅毒滴度≥1:16 和神经梅毒的比例分别为 8.6%(105/1227)和 7.8%(37/473),而血液传播的艾滋病毒感染者中则为 0。

结论

在艾滋病毒感染者中,HCV 传播强度与血液或性接触的特定暴露模式显著相关。男男性接触者慢性 HBV 感染率高于其他人群。应注意性传播途径感染 HIV 的艾滋病毒感染者中神经梅毒的高患病率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0da7/10933743/cd0e856560b1/publichealth_v10i1e46750_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0da7/10933743/cd0e856560b1/publichealth_v10i1e46750_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0da7/10933743/cd0e856560b1/publichealth_v10i1e46750_fig1.jpg

相似文献

1
Characteristics of Hepatitis B Virus, Hepatitis C Virus, and Syphilis Coinfection in People With HIV/AIDS Contracted Through Different Sources: Retrospective Study.乙型肝炎病毒、丙型肝炎病毒和梅毒合并感染在不同途径感染人类免疫缺陷病毒/艾滋病患者中的特征:回顾性研究。
JMIR Public Health Surveill. 2024 Feb 27;10:e46750. doi: 10.2196/46750.
2
Sexual transmission of hepatitis B in Mwanza, Tanzania.坦桑尼亚姆万扎地区乙型肝炎的性传播
Sex Transm Dis. 1997 Mar;24(3):121-6. doi: 10.1097/00007435-199703000-00001.
3
Seroprevalence of viral transfusion transmissible infections (HBsAg, anti-HCV, anti-HIV, Syphilis) and coinfection among healthy volunteer blood donors during 5-years in Luanda, Angola.安哥拉罗安达 5 年间健康献血者中病毒经输血传播感染(HBsAg、抗-HCV、抗-HIV、梅毒)及合并感染的血清流行率。
Braz J Infect Dis. 2023 Nov-Dec;27(6):103704. doi: 10.1016/j.bjid.2023.103704. Epub 2023 Nov 27.
4
Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.华中地区人类免疫缺陷病毒感染患者中乙型肝炎病毒和丙型肝炎病毒的流行情况。
Arch Virol. 2013 Sep;158(9):1889-94. doi: 10.1007/s00705-013-1681-z. Epub 2013 Apr 4.
5
Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon.喀麦隆埃代阿地区初次献血者人群中人类免疫缺陷病毒、乙型肝炎和丙型肝炎病毒以及梅毒感染的血清流行病学研究。
Int J Infect Dis. 2013 Oct;17(10):e832-7. doi: 10.1016/j.ijid.2012.12.007. Epub 2013 Jan 11.
6
Prevalence of human immunodeficiency virus, hepatitis C virus, hepatitis B virus and syphilis among individuals attending anonymous testing for HIV in Luanda, Angola.安哥拉罗安达匿名艾滋病毒检测人群中人类免疫缺陷病毒、丙型肝炎病毒、乙型肝炎病毒和梅毒螺旋体的流行情况。
S Afr Med J. 2013 Jan 24;103(3):186-8. doi: 10.7196/samj.6097.
7
Prevalence of hepatitis B and C and relationship to liver damage in HIV infected patients attending Joint Clinical Research Centre Clinic (JCRC), Kampala, Uganda.乌干达坎帕拉联合临床研究中心诊所(JCRC)就诊的HIV感染患者中乙型和丙型肝炎的患病率及其与肝损伤的关系。
Afr Health Sci. 2015 Jun;15(2):322-7. doi: 10.4314/ahs.v15i2.3.
8
Seroprevalence of hepatitis B, hepatitis C, human immunodeficiency virus, Treponema pallidum, and co-infections among blood donors in Kyrgyzstan: a retrospective analysis (2013-2015).吉尔吉斯斯坦献血者中乙型肝炎、丙型肝炎、人类免疫缺陷病毒、梅毒螺旋体及合并感染的血清流行率:一项回顾性分析(2013 - 2015年)
Infect Dis Poverty. 2017 Feb 21;6(1):45. doi: 10.1186/s40249-017-0255-9.
9
Prevalence of human immunodeficiency virus, syphilis, and hepatitis B and C virus infections in pregnant women: a systematic review and meta-analysis.孕妇人类免疫缺陷病毒、梅毒和乙型肝炎及丙型肝炎病毒感染的流行率:系统评价和荟萃分析。
Clin Microbiol Infect. 2023 Aug;29(8):1000-1007. doi: 10.1016/j.cmi.2023.03.002. Epub 2023 Mar 13.
10
Prevalence estimates of HIV, syphilis, hepatitis B and C among female sex workers (FSW) in Brazil, 2016.2016年巴西女性性工作者中艾滋病毒、梅毒、乙型肝炎和丙型肝炎的患病率估计
Medicine (Baltimore). 2018 May;97(1S Suppl 1):S3-S8. doi: 10.1097/MD.0000000000009218.

引用本文的文献

1
Slow virologic control but strong immune and metabolic recovery with dolutegravir-anchored therapy in an HIV cohort in Ghana.在加纳的一个艾滋病毒队列中,使用多替拉韦为主的治疗实现病毒学控制缓慢,但免疫和代谢恢复良好。
Virol J. 2025 Jul 19;22(1):247. doi: 10.1186/s12985-025-02873-w.
2
Enhancing public health surveillance: SARIMAX model incorporating Baidu search index for HCV prediction in China.加强公共卫生监测:结合百度搜索指数的SARIMAX模型用于中国丙型肝炎病毒预测
BMC Med Res Methodol. 2025 Apr 23;25(1):108. doi: 10.1186/s12874-025-02562-w.
3
The impact of the National Syphilis Prevention Program on the prevalence of syphilis among people living with HIV in China: a systematic review and meta-analysis.

本文引用的文献

1
Hepatitis B.乙型肝炎
Lancet. 2023 Mar 25;401(10381):1039-1052. doi: 10.1016/S0140-6736(22)01468-4. Epub 2023 Feb 9.
2
Prevalence of HBV Infection, Vaccine-Induced Immunity, and Susceptibility Among At-Risk Populations: US Households, 2013-2018.2013 - 2018年美国高危人群(家庭)中乙肝病毒感染率、疫苗诱导免疫力及易感性情况
Hepatology. 2021 Nov;74(5):2353-2365. doi: 10.1002/hep.31991. Epub 2021 Jul 13.
3
HIV, syphilis and hepatitis B coinfections in Mkushi, Zambia: a cross-sectional study.赞比亚姆库希地区的艾滋病毒、梅毒和乙型肝炎合并感染:一项横断面研究。
中国国家梅毒预防项目对艾滋病毒感染者中梅毒流行率的影响:一项系统评价和荟萃分析。
J Int AIDS Soc. 2025 Jan;28(1):e26408. doi: 10.1002/jia2.26408.
F1000Res. 2019 Apr 26;8:562. doi: 10.12688/f1000research.17983.2. eCollection 2019.
4
Hepatic benefits of HCV cure.丙型肝炎病毒治愈对肝脏的益处。
J Hepatol. 2020 Dec;73(6):1548-1556. doi: 10.1016/j.jhep.2020.08.006. Epub 2020 Aug 7.
5
Seropositivity rate and sociodemographic factors associated to HIV, HBV, HCV and syphilis among parturients from Irene Neto Maternity of Lubango city, Angola.安哥拉罗安达 Irene Neto 妇产医院产妇中 HIV、HBV、HCV 和梅毒的血清阳性率及社会人口学因素。
Sex Transm Infect. 2020 Dec;96(8):587-589. doi: 10.1136/sextrans-2019-054249. Epub 2020 May 18.
6
Seroprevalence and risk factors for HIV, HCV, HBV and syphilis among blood donors in Mali.马里献血者中 HIV、HCV、HBV 和梅毒的血清流行率及相关危险因素分析。
BMC Infect Dis. 2019 Dec 19;19(1):1064. doi: 10.1186/s12879-019-4699-3.
7
Screening for HBV, HCV, HIV and syphilis infections among bacteriologically confirmed tuberculosis prisoners: An urgent action required.对菌阳结核囚犯进行乙肝、丙肝、艾滋病毒和梅毒感染筛查:需要紧急行动。
PLoS One. 2019 Aug 22;14(8):e0221265. doi: 10.1371/journal.pone.0221265. eCollection 2019.
8
Post-transfusion hepatitis C virus infection among β-thalassaemic individuals with associated clinical parameters.输血后丙型肝炎病毒感染与相关临床参数在β-地中海贫血个体中的表现。
Indian J Med Res. 2018 Jun;147(6):581-587. doi: 10.4103/ijmr.IJMR_127_16.
9
Integrated point-of-care testing (POCT) of HIV, syphilis, malaria and anaemia in antenatal clinics in western Kenya: A longitudinal implementation study.肯尼亚西部产前诊所中 HIV、梅毒、疟疾和贫血的综合即时检测(POCT):一项纵向实施研究。
PLoS One. 2018 Jul 20;13(7):e0198784. doi: 10.1371/journal.pone.0198784. eCollection 2018.
10
Seroprevalence of transfusion-transmissible infections (HBV, HCV, syphilis and HIV) among prospective blood donors in a tertiary health care facility in Calabar, Nigeria; an eleven years evaluation.尼日利亚卡拉巴尔一家三级保健机构中预期献血者中输血传播感染(HBV、HCV、梅毒和 HIV)的血清流行率;十一年评估。
BMC Public Health. 2018 May 22;18(1):645. doi: 10.1186/s12889-018-5555-x.